BTK inhibitors as potential therapies for multiple sclerosis. Correale J. Lancet Neurol 2021;20:689-691.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Correale J. BTK inhibitors as potential therapies for multiple sclerosis. Lancet Neurol 2021;20:689-691.
PMID: 34418385